The requirement for extensive capital investment and complex infrastructure for in-house filling of biologics has prompted biopharmaceutical companies to leverage the expertise of service providers for fill / finish of biologics LONDON, Sept. 12, 2023 /PRNewswire/ — Roots Analysis has…